Describe the care delivered
Record presentation, diagnostics, microbiology, antimicrobial therapy, source control, and organ support from routine care.
SnapNSTI is a multicentre, non-randomized observational cohort describing how severe skin and soft-tissue infections are recognized, treated, and followed in routine acute care.
Consecutive local
enrolment window
Each centre reconstructs the pathway from routine records so that practice variation can be described clearly and future questions can be designed responsibly.
Record presentation, diagnostics, microbiology, antimicrobial therapy, source control, and organ support from routine care.
Align decision and treatment timing to admission so services can understand where pathways differ.
Summarize mortality, organ failure-free days, complications, reintervention, and recovery at 90 days.
Screen consecutive adult admissions with severe skin and soft-tissue infection during the local window.
Document presentation, diagnostic pathway, microbiology, timing, source control, and support.
Complete in-hospital data and the 90-day outcome record, with optional PROMs where locally approved.
Use aggregate findings to understand practice variation and design future studies responsibly.
Join a network studying the real-world pathways, resources, and outcomes that shape care for necrotizing soft-tissue infection.
Start with centre interest, local classification, and a plan for consecutive case ascertainment and 90-day follow-up.
See the participation pathway →Review the study description and contact the team about analytic, clinical, or implementation collaboration.
Explore collaborator routes →